Effect of gum treatment in hypertensive patients

Not Applicable

• Conditions: Hypertension; Periodontitis; C07.465.714.533; C14.907.489

• Registration Number: RBR-9d78qy
• Lead Sponsor: Faculdade de Odontologia de Araçatuba FOA

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Study Start: 2019-11-19
• Last Update Posted: 29 May 2023

Recruitment & Eligibility

• Status: ot yet recruiting
• Sex: Not specified
• Target Recruitment: Not specified

Inclusion Criteria

Patients over 35 years old; Have at least 12 teeth present; Diagnosis of generalized periodontitis according to periodontal classification: insertion loss in 2 non-adjacent interproximal sites, clinical insertion loss (CIN) greater than or equal to 3mm in 2 teeth, except for: gingival recession, dental caries, endoperiodontal injury, occurrence root fracture, presence of loss of insertion in the distal face of a second molar and associated with poor positioning or extraction of the third molar; a gingival condition would be described as localized when less than 30% of the teeth are affected; greater than 30% of teeth are affected by periodontal disease; Patients diagnosed with major refractory arterial hypertension equal to 140 and / or 90mmHg.

Exclusion Criteria

Smokers or former smokers less than 12 months old; Patient with anemia; Active cancer patient; Patient with blood disorders; Pregnancy; Patient with chronic kidney disease; Patient with decompensated Type II Diabetes Mellitus; Bacterial endocarditis; Having received some kind of prior periodontal therapy; Patient using any medication such as antibiotic or anti-inflammatory and systemic conditions that affect the progression or periodontal treatment; Patient undergoing chemotherapy and / or head and neck radiotherapy.

Study & Design

• Study Type: Intervention
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Improvement in periodontal clinical parameters such as clinical insertion level, bleeding on probing and probing depth, verified through probing depth, after intervention

Secondary Outcome Measures

Name	Time	Method
Reduction in serum levels of inflammatory mediators through blood tests and systemic arterial hypertension measured by the pressure device, analyzes performed after the intervention.